Vascular Health Linked to Early Alzheimer’s Brain Changes

Key Takeaways

• Brain vascular health is strongly linked to early Alzheimer’s-related brain changes.
• Noninvasive measures of blood flow and oxygenation reflect Alzheimer’s disease risk.
• Healthier vascular responses are associated with lower amyloid burden and larger hippocampal volume.
• Patients with mild cognitive impairment or dementia show poorer cerebrovascular indicators.
• Cerebrovascular dysfunction is part of the Alzheimer’s disease continuum.
• Low-cost, radiation-free vascular tools may support early screening and risk stratification.

Rethinking Early Alzheimer’s Risk Beyond Amyloid

A growing body of evidence suggests that vascular health and cerebral oxygen regulation may be integral to Alzheimer’s disease (AD) pathophysiology. A new study from the Mark and Mary Stevens Neuroimaging and Informatics Institute at the Keck School of Medicine of USC adds weight to this perspective.

Published in Alzheimer’s & Dementia, the study demonstrates that subtle disruptions in brain blood flow and oxygen delivery are associated with hallmark AD-related brain changes, even before pronounced cognitive symptoms appear.

Noninvasive Vascular Measures Reflect Brain Health

Researchers evaluated older adults with and without cognitive impairment using two resting-state, noninvasive tools:

• Transcranial Doppler ultrasound, assessing cerebral blood flow velocity
• Near-infrared spectroscopy (NIRS), measures cortical oxygenation

Advanced mathematical modeling translated these signals into vascular responsiveness indicators, reflecting how effectively the brain adapts blood flow and oxygen delivery to natural fluctuations in blood pressure and carbon dioxide levels.

Higher vascular indicator values, closer to those seen in healthy aging, were associated with:

• Lower amyloid plaque burden
• Larger hippocampal volume, a critical region for memory preservation

Participants with mild cognitive impairment or dementia showed poorer vascular profiles, positioning cerebrovascular dysfunction as part of the Alzheimer’s disease continuum.

Clinical Implications for Early Detection and Screening of Alzheimer’s

Senior author Meredith N. Braskie, PhD, noted that these vascular measures align with established MRI and PET biomarkers, offering complementary insights without radiation, contrast agents, or patient task demands.

From a clinical standpoint, these methods are:

• Cost-effective
• Scalable for population screening
• Well-suited for patients unable to tolerate advanced imaging

Arthur W. Toga, PhD, emphasized that Alzheimer’s disease involves meaningful vascular contributions, not solely amyloid and tau pathology, an important consideration for preventive strategies.

Toward Longitudinal Risk Stratification

While the study is cross-sectional and does not establish causality, longitudinal studies are underway to determine whether declining vascular indicators can predict future cognitive decline or therapeutic response.

Stay Ahead in Neurology: Don’t miss insights and breakthroughs shaping brain health care, visit the American Neurology Summit 2026

Tracking cerebrovascular signals over time may help clinicians identify high-risk individuals earlier and evaluate whether improving vascular health can mitigate Alzheimer’s-related brain changes.

Source:

Keck School of Medicine of USC